Review: taking Klonopin and Vyvanse together


Summary

Drug interactions are reported among people who take Klonopin and Vyvanse together. This review analyzes the effectiveness and drug interactions between Klonopin and Vyvanse. It is created by eHealthMe based on reports of 345 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Klonopin and Vyvanse >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Klonopin

Klonopin has active ingredients of clonazepam. It is often used in stress and anxiety. (latest outcomes from Klonopin 30,926 users)

Vyvanse

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Vyvanse 7,906 users)

On Jul, 20, 2016

345 people who take Klonopin, Vyvanse are studied.


Number of reports submitted per year:

Klonopin and Vyvanse drug interactions.

Drug effectiveness over time:

Klonopin:
  • < 1 month: 60.0% - (6 of 10 people)
  • 1 - 6 months: 47.0% - (18 of 38 people)
  • 6 - 12 months: 59.0% - (19 of 32 people)
  • 1 - 2 years: 44.0% - (17 of 38 people)
  • 2 - 5 years: 56.0% - (26 of 46 people)
  • 5 - 10 years: 66.0% - (16 of 24 people)
  • 10+ years: 75.0% - (6 of 8 people)
  • not specified: 100.0% - (4 of 4 people)
Vyvanse:
  • < 1 month: 44.0% - (13 of 29 people)
  • 1 - 6 months: 47.0% - (22 of 46 people)
  • 6 - 12 months: 53.0% - (25 of 47 people)
  • 1 - 2 years: 64.0% - (20 of 31 people)
  • 2 - 5 years: 80.0% - (28 of 35 people)
  • 5 - 10 years: 100.0% - (2 of 2 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 60.0% - (3 of 5 people)

Drug effectiveness by gender:

Klonopin:
  • female: 60.0% - (82 of 136 people)
  • male: 46.0% - (30 of 64 people)
Vyvanse:
  • female: 56.0% - (75 of 133 people)
  • male: 60.0% - (38 of 63 people)

Drug effectiveness by age:

Klonopin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 66.0% - (10 of 15 people)
  • 20-29: 70.0% - (39 of 55 people)
  • 30-39: 46.0% - (31 of 66 people)
  • 40-49: 46.0% - (19 of 41 people)
  • 50-59: 56.0% - (9 of 16 people)
  • 60+: 57.0% - (4 of 7 people)
Vyvanse:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 73.0% - (11 of 15 people)
  • 20-29: 56.0% - (31 of 55 people)
  • 30-39: 54.0% - (35 of 64 people)
  • 40-49: 58.0% - (23 of 39 people)
  • 50-59: 56.0% - (9 of 16 people)
  • 60+: 57.0% - (4 of 7 people)

Most common drug interactions over time *:

< 1 month:
  • anxiety
  • tremor
  • abdominal pain
  • drug ineffective
  • headache
  • nausea
  • blood pressure increased
  • depression
  • diarrhoea
  • exhaustion, fatigue, lethargy, tiredness, weariness
1 - 6 months:
  • delusional disorder, paranoid type
  • psychiatric evaluation abnormal
  • psychiatric symptom
  • schizophrenia simple
  • dizziness
  • headache
  • hyperglycaemia
  • hyperglycaemic unconsciousness
  • muscle cramps
  • nausea
6 - 12 months:
  • restless legs syndrome
  • bruise
  • canker sores
  • pica
  • fatigue
  • hyperglycaemia
  • hyperglycaemic unconsciousness
  • weight gain
  • anxiety aggravated
  • back pain
1 - 2 years:
  • insomnia
  • irritability
  • anxiety
  • constipation
  • dry mouth
  • fatigue
  • nausea
  • pain
  • restlessness
  • abnormal weight gain
2 - 5 years:
  • depression
  • excessive thirst
  • eye redness
  • memory loss
  • abdominal pain
  • back pain - low
  • discharge from the vagina
  • dry mouth
  • dry skin
  • eye swelling
5 - 10 years:
  • depression
  • loss of libido
  • abnormal weight gain
  • anxiety aggravated
  • appetite - increased
  • chest pain
  • gerd
  • heart rate
  • itching
  • migraine
10+ years:
  • accommodation disorder
  • anxiety
  • anxiety aggravated
  • appetite - increased
  • depression
  • itching
  • itching - burning eyes
  • memory impairment
  • mental disorder
  • mood swings
not specified:
  • depression
  • nausea
  • drug ineffective
  • vomiting
  • anxiety
  • fatigue
  • overdose
  • pain
  • drug effect decreased
  • malaise

Most common drug interactions by gender *:

female:
  • depression
  • nausea
  • fatigue
  • anxiety
  • pain
  • vomiting
  • drug ineffective
  • restless legs syndrome
  • dizziness
  • malaise
male:
  • drug ineffective
  • aggression
  • intentional overdose
  • insomnia
  • depression
  • fatigue
  • delusional disorder, paranoid type
  • drug effect decreased
  • drug intolerance
  • impaired driving ability

Most common drug interactions by age *:

10-19:
  • convulsion
  • insomnia
  • serotonin syndrome
  • aggression aggravated
  • agitation aggravated
  • alanine aminotransferase increased
  • anorexia
  • aspartate aminotransferase increased
  • chest discomfort
  • cyanosis
20-29:
  • malaise
  • abdominal pain upper
  • nausea
  • bruise
  • compartment syndrome
  • dehydration
  • peroneal nerve palsy
  • rectal ulcer
  • tendonitis
  • aggression
30-39:
  • depression
  • nausea
  • arthralgia
  • asthma
  • dizziness
  • fungal infection
  • gastric bypass
  • ill-defined disorder
  • osteoarthritis
  • psoriatic arthropathy
40-49:
  • depression
  • dry mouth
  • somnolence
  • fatigue
  • anxiety
  • diarrhoea
  • irritability
  • loss of libido
  • pain
  • restless legs syndrome
50-59:
  • drug ineffective
  • depression
  • fatigue
  • overdose
  • nausea
  • anxiety
  • abdominal pain
  • asthenia
  • drug effect decreased
  • drug withdrawal syndrome
60+:
  • balance disorder
  • accident
  • infection
  • limb crushing injury
  • lower limb fracture
  • multiple fractures
  • musculoskeletal disorder
  • pelvic fracture
  • spinal fracture
  • upper limb fracture

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Klonopin and Vyvanse?

Can you answer these questions?

More questions for: Klonopin, Vyvanse

You may be interested in these reviews

More reviews for: Klonopin, Vyvanse

On eHealthMe, Klonopin (clonazepam) is often used to treat stress and anxiety. Vyvanse (lisdexamfetamine dimesylate) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.